Australia markets closed

Ever Supreme Bio Technology Co., Ltd (6712.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
217.00-3.00 (-1.36%)
At close: 01:30PM CST
Currency in TWD

Valuation measures4

Market cap (intra-day) 15.91B
Enterprise value 14.90B
Trailing P/E 28.54
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)23.87
Price/book (mrq)9.12
Enterprise value/revenue 21.81
Enterprise value/EBITDA 21.62

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 315.56%
S&P500 52-week change 326.89%
52-week high 3227.50
52-week low 3170.00
50-day moving average 3197.68
200-day moving average 3196.14

Share statistics

Avg vol (3-month) 3494.86k
Avg vol (10-day) 31.07M
Shares outstanding 573.34M
Implied shares outstanding 673.34M
Float 8N/A
% held by insiders 143.96%
% held by institutions 15.41%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.99
Forward annual dividend yield 41.00%
Trailing annual dividend rate 31.81
Trailing annual dividend yield 30.82%
5-year average dividend yield 4N/A
Payout ratio 444.84%
Dividend date 3N/A
Ex-dividend date 429 May 2023
Last split factor 21099.649:1000
Last split date 329 May 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 June 2023


Profit margin 53.31%
Operating margin (ttm)41.26%

Management effectiveness

Return on assets (ttm)8.55%
Return on equity (ttm)19.42%

Income statement

Revenue (ttm)627.98M
Revenue per share (ttm)8.38
Quarterly revenue growth (yoy)4.60%
Gross profit (ttm)N/A
EBITDA 281.52M
Net income avi to common (ttm)334.81M
Diluted EPS (ttm)4.44
Quarterly earnings growth (yoy)22.10%

Balance sheet

Total cash (mrq)1.24B
Total cash per share (mrq)16.53
Total debt (mrq)11.82M
Total debt/equity (mrq)0.65%
Current ratio (mrq)8.08
Book value per share (mrq)24.36

Cash flow statement

Operating cash flow (ttm)375.15M
Levered free cash flow (ttm)263.91M